Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
May 06, 2025, 07:00 ET Human Longevity, Inc., Expands Cancer Prevention Offering by Selecting the ClearNote Health Avantect® Early Detection Pancreatic Cancer Test
Early Detection Developed by ClearNote Health, the Avantect test analyzes subtle epigenomic changes—specifically, 5-hydroxymethylcytosine (5hmC) markers—in cell-free DNA from a simple blood draw. The test is intended for use with patients at high-risk of pancreatic cancer, including those newly
More news about: Human Longevity, Inc.